Radiation mitigator and method of use thereof
Provided are methods useful for preventing and mitigating radiation injury, including acute radiation syndrome, comprising administering to a subject a therapeutically effective amount of a compound represented by formula I or a pharmaceutically acceptable salt thereof, wherein Z is —O— or —N(H)—.
1. A method for treating or preventing radiation-induced tissue injury, comprising co-administering to a subject in need thereof a therapeutically effective amount of a compound represented by formula II
or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of a compound represented by formula III
or a pharmaceutically acceptable salt thereof, thereby treating or preventing radiation-induced tissue injury in the subject.
2. The method of claim 1 , wherein the compounds are co-administered prior to exposure of the subject to radiation.
3. The method of claim 1 , wherein the compounds are co-administered after exposure of the subject to radiation.
4. The method of claim 1 , wherein the radiation-induced tissue injury is acute radiation-induced tissue injury.
5. The method of claim 1 , wherein the radiation-induced tissue injury is chronic radiation-induced tissue injury.
6. The method of claim 2 , wherein the radiation-induced tissue injury is acute radiation-induced tissue injury.
7. The method of claim 2 , wherein the radiation-induced tissue injury is chronic radiation-induced tissue injury.
8. The method of claim 3 , wherein the radiation-induced tissue injury is acute radiation-induced tissue injury.
9. The method of claim 3 , wherein the radiation-induced tissue injury is chronic radiation-induced tissue injury.
10. The method of claim 1 , wherein the tissue comprises gastrointestinal tissue.
11. The method of claim 1 , wherein the tissue comprises hematopoietic tissue.
12. The method of claim 1 , wherein the tissue comprises neural tissue.
13. The method of claim 1 , wherein the compound is administered orally.
14. The method of claim 1 , wherein the compound is administered parenterally.
15. The method of claim 1 , wherein the subject is a mammal.
16. The method of claim 1 , wherein the subject is a human.
17. The method of claim 1 , wherein the radiation-induced tissue injury is prevented.
18. The method of claim 1 , wherein the radiation-induced tissue injury is treated.